425 related articles for article (PubMed ID: 16432214)
1. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
2. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
3. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
5. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression.
Mukhopadhyay D; Tsiokas L; Sukhatme VP
Cancer Res; 1995 Dec; 55(24):6161-5. PubMed ID: 8521408
[TBL] [Abstract][Full Text] [Related]
6. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
7. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor.
Huckle WR; Roche RI
J Cell Biochem; 2004 Sep; 93(1):120-32. PubMed ID: 15352169
[TBL] [Abstract][Full Text] [Related]
10. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma].
Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T
Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427
[TBL] [Abstract][Full Text] [Related]
11. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of p53 by Pitx1.
Liu DX; Lobie PE
Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
[TBL] [Abstract][Full Text] [Related]
13. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis.
Sadasivam S; Gupta S; Radha V; Batta K; Kundu TK; Swarup G
Oncogene; 2005 Jan; 24(4):627-36. PubMed ID: 15580302
[TBL] [Abstract][Full Text] [Related]
14. Novel single nucleotide polymorphism of the VEGF gene as a risk predictor for gastroduodenal ulcers.
Kim YS; Park SW; Kim MH; Jang EJ; Park JS; Park SJ; Baik HW; Chung G; Hahm KB
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S131-9. PubMed ID: 19120886
[TBL] [Abstract][Full Text] [Related]
15. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines.
Shaked H; Shiff I; Kott-Gutkowski M; Siegfried Z; Haupt Y; Simon I
Cancer Res; 2008 Dec; 68(23):9671-7. PubMed ID: 19047144
[TBL] [Abstract][Full Text] [Related]
16. Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation.
Tomso DJ; Inga A; Menendez D; Pittman GS; Campbell MR; Storici F; Bell DA; Resnick MA
Proc Natl Acad Sci U S A; 2005 May; 102(18):6431-6. PubMed ID: 15843459
[TBL] [Abstract][Full Text] [Related]
17. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
Li C; Lin M; Liu J
Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
[TBL] [Abstract][Full Text] [Related]
18. Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways.
Afonyushkin T; Oskolkova OV; Philippova M; Resink TJ; Erne P; Binder BR; Bochkov VN
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1007-13. PubMed ID: 20185790
[TBL] [Abstract][Full Text] [Related]
19. The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound.
Ciribilli Y; Andreotti V; Menendez D; Langen JS; Schoenfelder G; Resnick MA; Inga A
PLoS One; 2010 Apr; 5(4):e10236. PubMed ID: 20422012
[TBL] [Abstract][Full Text] [Related]
20. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
